☆ 4.5 Letter

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

BLOOD CANCER JOURNAL (2022)

Get Full Text
Add to Collection

Journal

BLOOD CANCER JOURNAL
Volume 12, Issue 4, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41408-022-00653-1

Keywords

-

Categories

Oncology Hematology

Funding

  1. Janssen Oncology
  2. Janssen Global Services, LLC

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.